DSpace Repository

Curcumin: The epigenetic therapy

Show simple item record

dc.contributor.author Gaikwad, Anil Bhanudas
dc.date.accessioned 2023-12-26T10:44:06Z
dc.date.available 2023-12-26T10:44:06Z
dc.date.issued 2016
dc.identifier.uri https://www.sciencedirect.com/science/article/abs/pii/B9780128029725000068
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13525
dc.description.abstract The process of gene expression is tightly regulated by a series of interconnected epigenetic alterations including DNA methylation, covalent modifications of histones, or altered microRNA. The food components which are taken regularly play a significant role in altering the epigenetic modifications, and associated gene expression may act as important tools in curbing the diseases which involve epigenetic alterations. The polyphenolic compound curcumin (diferuloylmethane), possesses a large number of biological activities owing to which its use has been implicated in various diseases including cancer, respiratory diseases, metabolic disorders, and neurodegenerative disorders. These activities could be attributed partially to its DNA hypomethylating and histone acetylating property. In conclusion, curcumin is able to restore the epigenetic regulation balance and appears as an attractive preventive and/or therapeutic approach, and hence there is a need to study the epigenetic modifications promoted by its treatment. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Pharmacy en_US
dc.subject DNA methylation en_US
dc.subject microRNAs en_US
dc.title Curcumin: The epigenetic therapy en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account